Clarke Barlow
Vermögen: 3 733 $ am 31.07.2026
Vermögen: 3 733 $ am 31.07.2026
Clarke Colin Barlow is the founder of AMG Acquisition Corp., founded in 2021, serving as Independent Director since 2021.
Current jobs include Non-Executive Director at Neuroscientific Biopharmaceuticals Ltd. since 2023 and Member at Australian Institute of Co. Directors.
Former jobs include Non-Executive Director at Exopharm Ltd. and Non-Executive Director at Entropy Neurodynamics Ltd. in 2024.
Education includes undergraduate studies at The University of Western Australia.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMG ACQUISITION CORP. 11,59 % | 06.05.2025 | 533.340 ( 11,59 % ) | 3 733 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AMG ACQUISITION CORP. | Gründer | 01.06.2021 |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 17.11.2023 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| EXOPHARM | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
AMG Acquisition Corp.
AMG Acquisition Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen